DMRA
$21.96+3.29%
Damora Therapeutics Inc.Stock · HealthcareRussell 2000 · 0.04% of IWMNasdaq Composite · 0.004% of ONEQRussell 3000 · 0.002% of IWV
Damora Therapeutics Inc. total returns by year (including dividends)
As of market close, Oct 27, 2026
Damora Therapeutics Inc. total returns by year (2021–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $23.01 | $21.96 | 0.0% | -4.6% | |
| 2025 | $4.65 | $23.01 | 0.0% | +394.8% | |
| 2024 | $18.00 | $4.65 | 0.0% | -74.2% | |
| 2023 | $28.75 | $18.00 | 0.0% | -37.4% | |
| 2022 | $75.75 | $28.75 | 0.0% | -62.0% | |
| 2021 | $312.75 | $75.75 | 0.0% | -75.8% |
- Annualized
- -37.7%
- 2021–2026
- Average year
- +29.1%
- 5 full years
- Best year
- +394.8%
- 2025
- Worst year
- -75.8%
- 2021
- Positive years
- 1/5
- 20% up
Annualized (CAGR)
-37.7%
2021–2026
Average year
+29.1%
5 full years
Best year
+394.8%
2025
Worst year
-75.8%
2021
Positive years
1/5
20% up
Total return by period#
Annual
-200%0%200%
2021-76%'21
2022-62%'22
2023-37%'23
2024-74%'24
2025+395%'25
2026-4.6%'26
Methodology#
Total returns, dividends reinvested, measured on DMRA. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is Damora Therapeutics Inc.'s average annual return?
- Since 2021, Damora Therapeutics Inc. (DMRA) has returned about -37.7% a year (the compound annual growth rate) and an average calendar-year return of 29.1%.
- What were Damora Therapeutics Inc.'s best and worst years?
- Over 2021–2026, the best year was 2025 (+394.8%) and the worst was 2021 (-75.8%).
- How often is Damora Therapeutics Inc. up in a year?
- 1 of the 5 full years since 2021 were positive — about 20% of the time.
More on Damora Therapeutics Inc.
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100